CAS NO: | 197508-62-6 |
包装 | 价格(元) |
25μg | 电议 |
50μg | 电议 |
100μg | 电议 |
500μg | 电议 |
(±)14(15)-EET is biosynthesized in rat and rabbit liver microsomes by CYP450.
Cas No. | 197508-62-6 |
别名 | (±)14,15-EET, (±)14,15-EpETrE |
化学名 | (±)14(15)-epoxy-5Z,8Z,11Z-eicosatrienoic acid |
Canonical SMILES | CCCCC[C@@H]1[C@@H](O1)C/C=C\C/C=C\C/C=C\CCCC(O)=O |
分子式 | C20H32O3 |
分子量 | 320.5 |
溶解度 | DMF: >50 mg/ml (per Rao Maddipati),DMSO: >50 mg/ml (per Rao Maddipati),Ethanol: >50 mg/ml (per Rao Maddipati), |
储存条件 | Store at -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | (±)14(15)-EET is a metabolite of arachidonic acid that is formed via epoxidation of arachidonic acid by cytochrome P450.[1],[2] It prevents increases in leukotriene B4, ICAM-1, and chemokine (C-C motif) ligand 1 (CCL2) induced by oxidized LDL in primary rat pulmonary artery endothelial cells (RPAECs) when used at a concentration of 1 μM.[3] (±)14(15)-EET induces dilation of preconstricted isolated canine coronary arterioles (EC50 = 0.2 pM).[4] It reduces myocardial infarct size as a percentage of the area at risk in a canine model of ischemia-reperfusion injury induced by left anterior descending coronary artery (LAD) occlusion when administered at a dose of 0.128 mg/kg prior to occlusion or reperfusion.[5] Reference: |